1. Home
  2. LGVN vs PCLA Comparison

LGVN vs PCLA Comparison

Compare LGVN & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • PCLA
  • Stock Information
  • Founded
  • LGVN 2014
  • PCLA 2008
  • Country
  • LGVN United States
  • PCLA Japan
  • Employees
  • LGVN N/A
  • PCLA N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • PCLA Building Products
  • Sector
  • LGVN Health Care
  • PCLA Consumer Discretionary
  • Exchange
  • LGVN Nasdaq
  • PCLA Nasdaq
  • Market Cap
  • LGVN 17.6M
  • PCLA 18.6M
  • IPO Year
  • LGVN 2021
  • PCLA 2025
  • Fundamental
  • Price
  • LGVN $0.63
  • PCLA $0.30
  • Analyst Decision
  • LGVN Strong Buy
  • PCLA
  • Analyst Count
  • LGVN 2
  • PCLA 0
  • Target Price
  • LGVN $6.50
  • PCLA N/A
  • AVG Volume (30 Days)
  • LGVN 388.1K
  • PCLA 756.8K
  • Earning Date
  • LGVN 11-04-2025
  • PCLA 01-01-0001
  • Dividend Yield
  • LGVN N/A
  • PCLA N/A
  • EPS Growth
  • LGVN N/A
  • PCLA N/A
  • EPS
  • LGVN N/A
  • PCLA N/A
  • Revenue
  • LGVN $1,437,000.00
  • PCLA $5,065,197.00
  • Revenue This Year
  • LGVN N/A
  • PCLA N/A
  • Revenue Next Year
  • LGVN N/A
  • PCLA N/A
  • P/E Ratio
  • LGVN N/A
  • PCLA N/A
  • Revenue Growth
  • LGVN N/A
  • PCLA 5.26
  • 52 Week Low
  • LGVN $0.59
  • PCLA $0.27
  • 52 Week High
  • LGVN $2.24
  • PCLA $9.80
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 30.36
  • PCLA 34.18
  • Support Level
  • LGVN $0.59
  • PCLA $0.30
  • Resistance Level
  • LGVN $0.67
  • PCLA $0.50
  • Average True Range (ATR)
  • LGVN 0.05
  • PCLA 0.05
  • MACD
  • LGVN -0.01
  • PCLA 0.00
  • Stochastic Oscillator
  • LGVN 16.06
  • PCLA 11.78

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: